Is Pfizer a Buy?
Most of the headlines over the past two years about Pfizer (NYSE: PFE) have involved its vaccine for COVID-19. That makes sense. We have been in the middle of a pandemic. But the picture is clearing up (a little) with regard to what that means for the company financially.
The stock's value going forward will likely be based more on its other drugs and pipeline. And that is where management is focused. Let's dig in to see if there is enough once we get past COVID-19 to make the stock a good value right now.
Image source: Getty Images.
Source Fool.com
